lorundrostat
Jump to navigation
Jump to search
Indications
- refractory hypertension (investigational)[1]
Dosage
Adverse effects
- drug adverse effects of renin-angiotensin-aldosterone system inhibitors (RAAS inhibitors)
- drug adverse effects of antihypertensive agents
Mechanism of action
- aldosterone synthase inhibitor
More general terms
References
- ↑ 1.0 1.1 Laffin LJ, Rodman D, Luther JM et al Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension. The Target-HTN Randomized Clinical Trial. JAMA. 2023;330(12):1140-1150. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37690061 PMCID: PMC10493865 Free PMC article https://jamanetwork.com/journals/jama/fullarticle/2809625